Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think it can. It showed a lot of strength despite some selloff from traders who bought from 2s n 3s.
Into stronger hands for the next leg up.
About $200k in dollar volume. Follow the money.
Maybe so. Biotechs are hot.
Is there any Moderators here??
Wow!!! Took a nap and woke to this. Glad I loaded yesterday.
Cup and handle breakout
4s about to be history
$188k in t trades the past 3 days. Dilution better be done or them emails were fake.
Don't know how to post charts on this ihub app. Just links.
https://otcbb.swingtradebot.com/equities/RGBP:OTC
Not today. I do that on Monday. Laundry day.
I didn't find anyone pumping this.
Is this the same patent the applied for a while back.
Regen BioPharma Inc. Files Immuno-Oncology Patent Application on Synergy of Cannabidiol With NR2F6 Modulation
August 7, 2019
Unexpected Finding Opens up New Direction for Company's Cancer Immunotherapy Programs
SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Regen BioPharma Inc. (RGBP) and (RGBPP), announced today filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in an efficacious manner while appearing not to induce any form of toxicity.
In a series of experiments, Regen collaborators extracted immune system cells from mice called 'dendritic cells'. These cells where treated with cannabidiol, which caused suppression of their ability to activate cancer killing immune T cells. Surprisingly, in the presence of NR2F6 inhibition, the cannabidiol actually increased ability to activate T cells. The Company currently possesses small molecule inhibitors of NR2F6, as well as various genetic means such as inducers of RNA Interference, to block expression of NR2F6.
"Numerous studies have shown the NR2F6 is critically involved in the ability of cancer cells to resist death, as well as to possess other pathogenic properties (1-3)," according to Thomas Ichim, PhD, co-inventor of the patent and a senior scientific consultant to Regen BioPharma Inc. "It is very interesting that NR2F6 also acts as an 'immunological checkpoint' in that it prevents immune system activation (4-6). By using small molecules, as well as RNA interference, we are able to de-repress the immune system in cancer models. What is striking about the data disclosed today is that inhibition of NR2F6 not only increases activity of dendritic cells, but also changes cannabidiol from an immune inhibitor to an immune stimulator."
Chairman and CEO David Koos noted, "Checkpoint inhibitors are a new class of drugs, which include Ipilimumab (Yervoy® Bristol Myers Squibb, 2018 estimated sales of $1.5 Billion1), and Pembrolizumab (Keytruda® Merck, 2017 sales of $3.4 Billion2). Current checkpoint inhibitors act to augment immune responses but do not have direct anticancer effects. By creating approaches to inhibit NR2F6, the Company aims to develop a new class of checkpoint inhibitors that concurrently block tumor growth while enhancing the immune system."
.0029
This spiked to 29 last August. Let's hope history repeats itself.
94.5 million yesterday. 269 million today
Ihub n Twitter is not really pumping this.
Something's brewing behind closed doors for sure. This is worth a shot.
Don't know much about this yet. Just the share structure and it's a biotech. Unusual volume got my attention. And biotechs are hot. You never know, maybe a merger. Will see.
One word of COVID-19 on their next pr and it'll hit your target in seconds.
$90,500 hope that's it for a while.
Took some
Any chart expert here? Notice the nice cup and handle pattern.
98k in T trades the past two days.
This is about to run in the coming days. about 3 million in contracts in the 1st half of the year so far. I think they can triple that next half. Once dilution is done, they will be putting out pr's. Same scenarios as tpt*w and opt*i did.
Nope. Look again.
Lvl2 clean so far today
Yes, seems to be winding down thou.
Bullish bullish bullish technicals analysis.
http://otcbb.swingtradebot.com/equities/GAXY:OTC
Doubled my position here @35
Some GAXY numbers:
7/15/20 OS was 861,000,000
7/31/20 OS was 1,486,000,000
625,000,000 was added to the OS the past 2 weeks.
Email from IR on 7/30/20 said about $500k notes was being converted and almost done.
Here are some ifs:
625,000,000 × 0.0008=$500,000
625m × 0.001=$625,000
625m × 0.0015=$937,000
625m × 0.002=$1,250,000
625m × 0.0025=$1,562,500
625m × 0.003=$1,875,000
625m × 0.0035=$2,187,500
625m × 0.004=$2,500,000
Dollar volume on 30th and 31st of July was
$1,525,000
VWAP this past week was 0.0030
VWAP for the month was 0.0041
VWAP for the past 3 months was 0.0040
My guess is notes are done or it's very little left. Which will be done on Monday.
After that 500k are done, No notes are due till November. I'm no filings reader expert so someone correct me if I'm wrong.
Expect a pr when notes are done.
Contracts, partnerships.....
Over $700k in dollar volume so far.
Follow the money.
More contracts announced in the next two weeks. imo
Notes about done. imo
3c-5c is my guess in a few weeks.
Some great dd on Twitter
$GAXY
So GAXY is supplying products to BOXL.
732k in dollar volume. Follow the money!!
Mm's playing games here. Just look at the buys/sells transaction. Rookies are falling for it. Hold them shares and take their naked shares away. This will pop. imo
That's my hunch. DSS acquiring SHRG with cash + shares.
$SHRG @ .21 severely UNDERVALUED.
Profitable and growing. Definitely going to dollars soon.